BEYOND BIOTECH: UK LIFE SCIENCES FORECAST

Once the darling of CRE across Europe and the US, life sciences has encountered unique challenges throughout 2024. From new demand variables to oversupply, the UK’s owners, developers and investors have had to rethink their strategy as to how to create more inclusive, all-encompassing innovation campuses and districts to attract and retain the wider varietal of talent entering the biotech space. From new sectors and new strategies, as well as understanding how today’s financing, development, and operations trends have shifted, hear from our experts on what the new year will hold for biotech and beyond.